Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
XERS · against 1,372 other Healthcare companies
Ranked #1,295 of 1,373 · scores higher than 6% of peers · safety percentile 6
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)138 peers with a safety percentile of 0–9, including XERS · Click a bar to see the companies
Mainly because of its debt / equity, current ratio and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | XERS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | Not reported | 0.24× | — | — | 33% |
| BetaLower is better · 1,320 reported | 0.85 | 0.53 | 31% | 33% | |
| Current ratioHigher is better · 1,338 reported | 1.45× | 2.62× | 25% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 1,291 | 773M USD | 6 | 64 | |
| 1,292 | 13.9B SEK (≈$1.4B) | 6 | 48 | |
| 1,293 | 14.2B CNY (≈$2.0B) | 6 | 10 | |
| 1,294 | 18.7B CNY (≈$2.6B) | 6 | 51 | |
| 1,295 | 1.9B USD | 6 | 47 | |
| 1,296 | 8.8B USD | 6 | 31 | |
| 1,297 | 7.3B USD | 6 | 32 | |
| 1,298 | 48.9B USD | 5 | 54 | |
| 1,299 | 272.9B BRL (≈$49.1B) | 5 | 43 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score